title: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects.
abstract: Part 2 of this 4-part continuing medical education series continues with a discussion of the prevention and management of gastrointestinal side effects associated with corticosteroid use, including peptic ulcer disease, gastrointestinal bleeding, and pancreatitis, followed by a review of corticosteroid-related endocrinologic side effects, such as diabetes, adrenal suppression, and Cushing syndrome.
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Avrom
authors.initials: A
authors.lastname: Caplan
authors.affiliation: Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
authors.forename: Nicole
authors.initials: N
authors.lastname: Fett
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Misha
authors.initials: M
authors.lastname: Rosenbach
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Victoria P
authors.initials: VP
authors.lastname: Werth
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: robert.micheletti@uphs.upenn.edu.
authors.forename: Robert G
authors.initials: RG
authors.lastname: Micheletti
mesh_terms: D000311:Adrenal Glands / Q000187:drug effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D015190:Blood Glucose Self-Monitoring; D003480:Cushing Syndrome / Q000139:chemically induced / Q000628:therapy; D003920:Diabetes Mellitus / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010195:Pancreatitis / Q000139:chemically induced; D010437:Peptic Ulcer / Q000139:chemically induced / Q000517:prevention & control*; D054328:Proton Pump Inhibitors / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D054328:Proton Pump Inhibitors
keywords: Cushing syndrome; adrenal suppression; diabetes; gastrointestinal bleeding; glucocorticoids; peptic ulcer disease; side effects; steroids